by nall486 | May 22, 2017 | Research
Full title: A phase II study of dasatinib followed by imatinib in newly diagnosed, previously untreated patients with chronic phase CML Kinase Inhibition with Sprycel Start‐up Cancer type: Chronic Myeloid Leukaemia Status: In set up Brief description: The KISS Study...
